Loading stock data...

Sanofi India Limited

NSE: SANOFI BSE: SANOFI

NSE
6,147.00 -27.50 (-0.45%)

Prev Close

6174.5

Open Price

6169

Volume

9,457

Today Low / High

6113.5 / 6212

52 WK Low / High

4902 / 10524.95

Range

5,840 - 6,454

BSE
6,162.30 -14.10 (-0.23%)

Prev Close

6176.4

Open Price

6176

Volume

595

Today Low / High

6119.05 / 6204.8

52 WK Low / High

4145.9 / 10526.05

Range

5,854 - 6,470

The stock is currently trading on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). On the NSE, the stock is priced at 6147 (target range: 5,840 - 6,454), reflecting a change of -27.5 (-0.44538%). On the BSE, it is listed at 6162.3 (target range: 5,854 - 6,470), showing a change of -14.1 (-0.22829%). The stock price is currently in decline on both exchanges, signaling a downtrend. If you're considering investing in this stock, it's important to monitor the situation closely.

06 Jun 6,169.00 -0.36%
05 Jun 6,193.50 -0.31%
04 Jun 6,244.50 -1.02%
03 Jun 6,180.00 0.66%
02 Jun 6,199.00 -0.94%
30 May 6,180.50 0.19%
29 May 6,210.00 -0.01%
28 May 6,206.50 0.05%
27 May 6,295.50 -1.41%
26 May 6,275.50 0.12%
23 May 6,265.00 0.17%
22 May 6,377.00 -1.76%
21 May 6,309.00 1.08%
20 May 6,360.00 -0.89%
19 May 6,343.00 -1.14%
16 May 6,310.00 -0.38%
15 May 6,200.00 1.85%
14 May 5,954.00 1.56%
13 May 5,912.00 0.30%
12 May 5,875.00 -0.37%
09 May 5,700.00 2.20%

Sanofi India Limited Graph

Sanofi India Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for Sanofi India Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 6,147.00, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 6,162.30 6,223.92 5,601.53 - 6,846.32
6,285.55 5,028.44 - 7,542.66
6,347.17 4,443.02 - 8,251.32
Bearish Scenario 6,162.30 6,100.68 5,490.61 - 6,710.74
6,039.05 4,831.24 - 7,246.86
5,977.43 4,184.20 - 7,770.66

Overview of Sanofi India Limited

ISIN

INE058A01010

Industry

Drug Manufacturers - General

Vol.Avg

19,739

Market Cap

141,565,410,000

Last Dividend

117

Official Website

Visit Website

IPO Date

2002-07-01

DCF Diff

1,585.82

DCF

4,561

Financial Ratios Every Investor Needs

Stock Dividend of SANOFI

Date Label Adj Dividend Dividend Record Date Payment Date Declaration Date
2025-04-25 April 25, 25 117 117 2025-04-25 2025-06-14
2024-05-03 May 03, 24 117 117 2024-05-03 2024-05-24
2024-03-07 March 07, 24 50 50 2024-03-07 2024-03-20
2023-04-28 April 28, 23 183 183 2023-04-28 2023-06-10
2022-08-05 August 05, 22 193 193 2022-08-08 2022-08-22

Stock Rating Details for SANOFI

Metric Value Recommendation
Overall Rating A- Buy
DCF Score 4 Buy
ROE Score 5 Strong Buy
ROA Score 5 Strong Buy
Debt-to-Equity (DE) Score 4 Buy
Price-to-Earnings (PE) Score 1 Strong Sell
Price-to-Book (PB) Score 1 Strong Sell

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2024-12-31 2,013.20 Cr 979.30 Cr 1,033.90 Cr 0.5136 0.00 Cr 0.00 Cr 454.10 Cr 413.30 Cr 179.45 469.60 Cr 0.2053
2023-12-31 2,851.10 Cr 1,257.40 Cr 1,593.70 Cr 0.5590 0.00 Cr 371.70 Cr 1,219.30 Cr 602.90 Cr 261.78 886.80 Cr 0.2115
2022-12-31 2,770.10 Cr 1,189.60 Cr 1,580.50 Cr 0.5706 0.20 Cr 74.90 Cr 734.00 Cr 620.60 Cr 269.47 907.90 Cr 0.2240
2021-12-31 2,924.60 Cr 1,306.80 Cr 1,617.80 Cr 0.5532 0.40 Cr 80.40 Cr 763.60 Cr 944.40 Cr 410.06 1,326.10 Cr 0.3229
2020-12-31 2,868.80 Cr 1,253.60 Cr 1,615.20 Cr 0.5630 0.30 Cr 75.00 Cr 723.50 Cr 477.60 Cr 207.38 761.20 Cr 0.1665

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2024-12-31 283.80 Cr 1,611.80 Cr 751.20 Cr 860.6000 Cr 19.30 Cr -264.50 Cr 499.80 Cr 329.30 Cr 0.00 Cr 0.00 Cr -43.50 Cr 719.2000 Cr
2023-12-31 394.50 Cr 1,714.80 Cr 699.60 Cr 1,015.2000 Cr 19.00 Cr -375.50 Cr 663.80 Cr 323.30 Cr 0.00 Cr 0.00 Cr 4.40 Cr 651.3000 Cr
2022-12-31 1,004.90 Cr 2,071.70 Cr 795.90 Cr 1,275.8000 Cr 23.60 Cr -981.30 Cr 408.00 Cr 324.00 Cr 4.70 Cr 0.00 Cr -4.30 Cr 740.6000 Cr
2021-12-31 1,538.00 Cr 3,061.00 Cr 835.40 Cr 2,225.6000 Cr 24.60 Cr -1,513.40 Cr 392.40 Cr 341.70 Cr 356.50 Cr 0.00 Cr -9.10 Cr 749.6000 Cr
2020-12-31 1,197.40 Cr 2,918.50 Cr 799.50 Cr 2,119.0000 Cr 22.60 Cr -1,174.80 Cr 368.00 Cr 362.90 Cr 356.10 Cr 0.00 Cr -24.90 Cr 686.8000 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2024-12-31 461.5000 Cr -19.2000 Cr -392.4000 Cr 425.1000 Cr -110.7000 Cr 283.8000 Cr -36.4000 Cr 562.4000 Cr 0.0000 Cr -384.6000 Cr 68.7000 Cr
2023-12-31 230.4000 Cr 37.5000 Cr -878.3000 Cr 196.1000 Cr -610.4000 Cr 406.5000 Cr -34.3000 Cr 602.9000 Cr 0.0000 Cr -868.3000 Cr -255.8000 Cr
2022-12-31 398.7000 Cr 650.9000 Cr -1,582.7000 Cr 376.5000 Cr -533.1000 Cr 1,004.9000 Cr -22.2000 Cr 864.3000 Cr -8.0000 Cr -1,573.0000 Cr -31.4000 Cr
2021-12-31 558.8000 Cr 630.8000 Cr -849.0000 Cr 535.8000 Cr 340.6000 Cr 1,538.0000 Cr -23.0000 Cr 1,257.6000 Cr -6.6000 Cr -840.6000 Cr -33.6000 Cr
2020-12-31 611.1000 Cr 276.4000 Cr -810.0000 Cr 569.7000 Cr 77.5000 Cr 1,197.4000 Cr -41.4000 Cr 677.2000 Cr -4.6000 Cr -803.8000 Cr -22.2000 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2024-12-31 514.90 Cr 249.80 Cr 265.10 Cr 0.5149 108.70 Cr 91.30 Cr 39.64 132.20 Cr 0.1773
2024-09-30 524.00 Cr 260.00 Cr 264.00 Cr 0.5038 110.70 Cr 82.20 Cr 35.69 122.00 Cr 0.1569
2024-06-30 463.50 Cr 290.30 Cr 173.20 Cr 0.3737 106.70 Cr 103.20 Cr 44.81 101.50 Cr 0.2227
2024-03-31 732.40 Cr 410.80 Cr 321.60 Cr 0.4391 208.90 Cr 136.60 Cr 59.31 198.70 Cr 0.1865
2023-12-31 693.90 Cr 382.40 Cr 311.50 Cr 0.4489 177.20 Cr 137.70 Cr 59.79 199.40 Cr 0.1984

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2024-12-31 283.80 Cr 56.20 Cr 340.00 Cr 231.00 Cr 499.80 Cr 1,126.80 Cr 329.30 Cr 1,611.80 Cr 751.20 Cr
2024-06-30 248.20 Cr 14.70 Cr 262.90 Cr 179.80 Cr 356.20 Cr 876.80 Cr 329.90 Cr 1,360.30 Cr 675.70 Cr
2024-03-31 -394.50 Cr 789.00 Cr 394.50 Cr 0.00 Cr 0.00 Cr 394.50 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2023-12-31 406.50 Cr 19.80 Cr 406.50 Cr 131.70 Cr 663.80 Cr 1,248.00 Cr 323.30 Cr 1,714.80 Cr 699.60 Cr
2023-09-30 -448.10 Cr 896.20 Cr 448.10 Cr 0.00 Cr 0.00 Cr 448.10 Cr 0.00 Cr 0.00 Cr 0.00 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2024-06-30 103.20 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-03-31 136.60 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2023-12-31 137.70 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2023-09-30 151.90 Cr 19.80 Cr 0.00 Cr 0.00 Cr 19.80 Cr 467.90 Cr 448.10 Cr 0.00 Cr 19.80 Cr
2023-06-30 122.90 Cr 19.60 Cr 0.00 Cr 0.00 Cr 19.60 Cr 448.10 Cr 428.50 Cr 0.00 Cr 19.60 Cr

Splits History

Date Label Split Ratio
No split history data available.

Similar Stocks: Drug Manufacturers - General

Company Name Symbol Price Market Cap Volume
Cipla Limited CIPLA ₹1,504.20 ₹1,214,852,088,000.00 ₹861,736.00
Abbott India Limited ABBOTINDIA ₹31,630.00 ₹672,115,359,000.00 ₹16,700.00
GlaxoSmithKline Pharmaceuticals Limited GLAXO ₹3,438.50 ₹582,502,531,000.00 ₹149,103.00
Gland Pharma Limited GLAND ₹1,642.00 ₹270,529,352,000.00 ₹95,999.00
Pfizer Limited PFIZER ₹5,706.50 ₹261,059,250,050.00 ₹23,368.00
Sanofi India Limited SANOFI ₹6,147.00 ₹141,565,410,000.00 ₹9,457.00
Marksans Pharma Limited MARKSANS ₹251.95 ₹114,174,669,800.00 ₹1,156,187.00

Key Executives

Senior Director of Public Affairs and Head of Public Affairs & Market Access
Mr. Nakul Verma

Gender: male

Year Born:

Senior Director of Accounting & Taxation
Mr. M. K. Narayanaswamy B.Com.,A.I.C.W.A.

Gender: male

Year Born: 1955

Chief Financial Officer & Whole Time Director
Mr. Rachid Ayari

Gender: male

Year Born: 1975

Site Director of Goa & Whole-time Director
Ms. Renee Amonkar

Gender: female

Year Born: 1964

Sales & Customer Engagement Head - Diabetes and Senior Director of Diabetes
Mr. N. Suresh Babu

Gender: male

Year Born:

Company Secretary & Compliance Officer
Mr. Arjun Jasvant Thakkar

Gender: male

Year Born:

Senior Director of Ethics & Business Integrity, South Asia
Mr. Bratin Bag

Gender: male

Year Born:

Senior Director of Regulatory Affairs
Ms. Yasmin Shenoy

Gender: female

Year Born:

Head of Country Procurement - India
Mr. Sanjay V. Chavan

Gender: male

Year Born: 1962

People & Culture Director
Ms. Surabhi Kaur

Gender: female

Year Born:

FAQs about Sanofi India Limited

Who is the CEO of the company?

The CEO is Mr. Rachid Ayari.

What is the current market price of the stock?

The current price is ₹6,147.00.

What is the 52-week price range?

The range is ₹4902-10524.95.

What is the market capitalization of the company?

The market capitalization is ₹14,156.54 crores.

What is the dividend yield?

The dividend yield is 1.90%.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is 34.25.

Which sector does the company belong to?

The company operates in the Healthcare sector.

What does the company do?

Overview of Sanofi India Limited (ISIN: INE058A01010) is a leading Drug Manufacturers - General in India. With a market capitalization of ₹14,156.54 crores and an average daily volume of 19,739 shares, it operates in the Drug Manufacturers - General. The company last declared a dividend of ₹117.

Welcome to the Investing and Trading Information platform: InvesTrack.in

Note: This platform is for educational and informational purposes only. Do not consider anything as financial advice.

QUICK LINKS

Home
About us
Contact us
Privacy Policy
Disclaimer
Sitemap
Investing
Trading
Top Brokers
Tools
Live Analysis

STAY CONNECTED

Follow Us On Social Media
Get Latest Update On Social Media
Facebook Instagram Twitter

General Disclaimer: InvesTrack is an educational platform and not any type of investment advisory platform. Our Blog and videos are based on countless hours of research and experience, which you can use as a guide for your research purposes. None of our content should be considered a piece of investment advice. Earning Disclosure: InvesTrack is a community supported platform. We may earn a commission when you make a purchase through one of our links at no extra cost to you. Note: We are not SEBI Registered Advisors. This website is purely for training and educational purposes. We shall not be responsible for your profit or loss.

© Copyright 2024 - 2025 | InvesTrack